Wuxi AppTec Co (STU:WX8) 5-Year EBITDA Growth Rate : 37.00% (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co 5-Year EBITDA Growth Rate?

Wuxi AppTec Co's EBITDA per Share for the three months ended in Mar. 2025 was €0.19.

During the past 12 months, Wuxi AppTec Co's average EBITDA Per Share Growth Rate was 21.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 26.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 37.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 30.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Wuxi AppTec Co was 50.20% per year. The lowest was 12.60% per year. And the median was 30.35% per year.

Competitive Comparison of Wuxi AppTec Co's 5-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Wuxi AppTec Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuxi AppTec Co's 5-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's 5-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Wuxi AppTec Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Wuxi AppTec Co (STU:WX8) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Wuxi AppTec Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuxi AppTec Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (STU:WX8) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

WUXIF:USA WUXAY:USA 02359:Hong Kong WX8:Germany 603259:China

Address

288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131

Website

https://www.wuxiapptec.com

Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.

Wuxi AppTec Co Headlines

No Headlines